Stable growth will give big boost to leading pharmaceutical shares

Published: 2009-01-14 07:00:00

Updated: 2009-01-14 07:00:00

Boosted by flagship ethical products and more eased pricing rules on generic products by the government will give a green light to stocks of major pharmaceutical firms, such as Dong-A Pharm, Hanmi Pharm and Bukwang Pharm, according to analysts of local securities.

They said that despite the po...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK